Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-17

Clinical Trial Update: Perioperative Dexmedetomidine to Reduce Post-procedure Grief Following Second-trimester Dilation and Evacuation [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating perioperative dexmedetomidine to reduce post-procedure grief after second-trimester dilation and evacuation, with status not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Stanford University | Conditions: Abortion, Stillbirth | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING